Dunsire Deborah 4
4 · Ultragenyx Pharmaceutical Inc. · Filed May 19, 2025
Insider Transaction Report
Form 4
Dunsire Deborah
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-05-15+10,787→ 10,787 totalExercise: $34.84Exp: 2035-05-15→ Common Stock (10,787 underlying) - Award
Common Stock
2025-05-15+5,740→ 30,815 total
Footnotes (2)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 15, 2026.
- [F2]The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 15, 2026.